Repurposing of medications for pulmonary arterial hypertension-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Repurposing of medications for pulmonary arterial hypertension

Published:2020-10 Issue:4 Volume:10 Page:1-12
ISSN:2045-8940
Container-title:Pulmonary Circulation
language:en
Short-container-title:Pulm. circ.

Author:

Toshner Mark¹^ORCID,Spiekerkoetter Edda²,Bogaard Harm³,Hansmann Georg⁴,Nikkho Sylvia⁵,Prins Kurt W.⁶

Affiliation:

1. Department of MedicineUniversity of CambridgeCambridgeUK

2. Department of MedicineStanford University School of MedicineStanfordCAUSA

3. Department of Pulmonary MedicineVrije Universiteit AmsterdamAmsterdamNetherlands

4. Department of Pediatric Cardiology and Critical CareHannover Medical SchoolHannoverGermany

5. Bayer PharmaceuticalsClinical Development PulmonologyBerlinGermany

6. Lillehei Heart InstituteUniversity of MinnesotaMinneapolisMNUSA

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1177/2045894020941494

Reference88 articles.

1. Drug repositioning and repurposing: terminology and definitions in literature;Langedijk J;Drug Discov Today,2015

2. Drug repurposing: progress, challenges and recommendations;Pushpakom S;Nat Rev Drug Discov,2019

3. Drug repurposing: progress, challenges and recommendations;Pushpakom S;Nat Rev Drug Discov,2019

4. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension;Barst RJ;N Engl J Med,1996

5. Sildenafil citrate therapy for pulmonary arterial hypertension;Galiè N;N Engl J Med,2005

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mast Cells in Cardiac Remodeling: Focus on the Right Ventricle;Journal of Cardiovascular Development and Disease;2024-02-04

2. Pulmonary arterial hypertension nanotherapeutics: New pharmacological targets and drug delivery strategies;Journal of Controlled Release;2024-01

3. Medical Management of Pulmonary Arterial Hypertension: Current Approaches and Investigational Drugs;Pharmaceutics;2023-05-24

4. Fabrication of Novel Omeprazole-Based Chitosan Coated Nanoemulgel Formulation for Potential Anti-Microbia; In Vitro and Ex Vivo Characterizations;Polymers;2023-03-04

5. Therapeutic targeting of mineralocorticoid receptors in pulmonary hypertension: Insights from basic research;Frontiers in Cardiovascular Medicine;2023-01-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3